Showing results (281-290 of 534) with videos related to

Sort By:
Pageof 54
JAMA Neurology|June 16, 2020
Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled TrialRadu Tanasescu, Christopher R Tench, Cris S Constantinescu, et al.
Open Medicine (Warsaw, Poland)|October 3, 2023
Trial protocol: Feasibility of neuromodulation with connectivity-guided intermittent theta-burst stimulation for improving cognition in multiple sclerosisCaroline Blanchard, Blanca De Dios Perez, Tierney Tindall, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2025
Proinflammatory Effect of Mesenchymal Stem Cells From Patients With Multiple Sclerosis: Potential Modulation TargetsRadu Tanasescu, Nanci Frakich, Kiranmai Gumireddy, et al.
Scientific Reports|November 8, 2017
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulationAtheer Zgair, Jong Bong Lee, Jonathan C M Wong, et al.
Multiple Sclerosis and Related Disorders|December 14, 2025
Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case seriesLucas P Garfinkel, Judy Diep, Anjela Anand, et al.
Revista De Chirurgie, Oncologie, Radiologie, O.R.L., Oftalmologie, Stomatologie. Chirurgie|November 1, 1980
[Chemical medullosclerosis with 40-percent sodium salicylate, combined with splanchnicosympathectomy, with or without contralateral adrenalectomy, in severe essential arterial hypertension. II. Clinical, paraclinical and technical studies. Results for a period of 2 to 20 years (original concepts and therapy)]F Mandache, V Prodescu, S Constantinescu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2012
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72Azza Ismail, Johnathan Cooper-Knock, J Robin Highley, et al.
Acta Physiologica (Oxford, England)|February 24, 2015
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cellsL Jean-Gilles, M Braitch, M L Latif, et al.
Biochemical and Biophysical Research Communications|October 13, 2007
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell deathAndriani Athanasiou, Anna B Clarke, Amy E Turner, et al.
Research Square|March 30, 2023
Eye movement defects in KO zebrafish reveals SRPK3 as a causative gene for an X-linked intellectual disabilityYu-Ri Lee, Mervyn G Thomas, Arkaprava Roychaudhury, et al.
Pageof 54